PDL Practice Alert
Important changes to legislation regarding pseudoephedrine and naloxone On February 1, 2016, the scheduling on Naloxone changed from S4 to S3 for the treatment of opioid overdose. The two current …
Beware the Schedule 8 minefield
The importance of correctly storing and recording transactions of Schedule 8 medicines has been reinforced by three recent pharmacy disciplinary hearings. Schedule 8 medicines were the common factor in each …
Introducing AJP Daily
Welcome to AJP Daily – our new email newsletter that brings you the latest and most relevant pharmacy news, views, opinions and discussion every day. Building on the Australian Journal …
Pain management proving a real problem
Australians have one of the world’s highest instances of regular pain a new international survey reveals. A survey across 14 countries found that 97% of Australians say they suffer from …
Patients must have the facts: Guild
Be honest about the true cost of the $1 discount, Guild urges pharmacists Australian pharmacists must be honest about the impact of the $1 PBS co-pay discount on their chances …
Introducing AJP Daily
Our new daily newsletter launches on 1 March Get ready for AJP Daily – our new daily email newsletter bringing you the latest and most relevant news, views, opinions and …
Codeine decision by May
Rescheduling review announced by department as May decision date looms A decision on the controversial rescheduling of codeine is expected by May 2016, following a safety review, Department of Health …
Give us control: Guild
Guild wants pharmacy to play a key role in chronic health management, despite resistance Community pharmacy should be empowered to play a vital role in the management and prevention of …